ASSOCIATION OF ALLELE-SPECIFIC HLA EXPRESSION AND HISTOPATHOLOGIC PROGRESSION OF CERVICAL-CARCINOMA

Citation
Wj. Vandriel et al., ASSOCIATION OF ALLELE-SPECIFIC HLA EXPRESSION AND HISTOPATHOLOGIC PROGRESSION OF CERVICAL-CARCINOMA, Gynecologic oncology, 62(1), 1996, pp. 33-41
Citations number
57
Categorie Soggetti
Oncology,"Obsetric & Gynecology
Journal title
ISSN journal
00908258
Volume
62
Issue
1
Year of publication
1996
Pages
33 - 41
Database
ISI
SICI code
0090-8258(1996)62:1<33:AOAHEA>2.0.ZU;2-U
Abstract
Immunohistochemical studies have shown that loss of HLA expression is observed in cervical carcinomas but not in premalignant CIN lesions, i ndicating that downregulation of HLA is linked to tumor progression. T he present study was performed to investigate whether the degree of HL A expression in cervical cancer correlates with more advanced disease as defined by histopathological features. Frozen tissue sections from 49 patients with squamous carcinoma of the cervix FIGO stage IB to IIB were stained with HLA class I monomorphic, locus- and allele-specific monoclonal antibodies. Histological data indicative of local disease, i.e., depth of invasion, tumor size, stage, and systemic spread of th e disease, such as tumor-positive lymph nodes, were collected by revie wing the histological slides. Univariate analysis revealed that loss o f HLA-A locus and A2-allele expression showed a positive, significant correlation with both presence of tumor-positive lymph nodes (P = 0.04 and 0.02, respectively) and the number of lymph nodes involved (both P = 0.04). These results strongly support the idea that, specifically in an immunogenic cancer type such as cervical cancer, tumor cells esc ape immunosurveillance and gain growth advantage by allele-specific do wnregulation of the HLA-A2 molecule. In view of the development of imm unotherapeutical interventions in cancer, upregulation of HLA class I molecules may prove to be a useful additional tool in the combat again st immunogenic tumors. (C) 1996 Academic Press, Inc.